Neurotensin, a neuroendocrine peptide present in gut and brain has previously been found in pancreatic tumours secreting several other peptides. We report here the first case of a patient with a neurotensinsecreting adenocarcinoma of the bronchus.
Introduction
In recent years a number of new regulatory peptides have been isolated from the gastrointestinal tract and central nervous system. Neurotensin, originally found in bovine hypothalamus and subsequently isolated from the human gastrointestinal tract, is a new member of this peptide group which has a wide range of potent biological actions. In man these include inhibition of gastric acid secretion, relaxation of the lower oesophageal sphincter and vasoconstriction in adipose tissue (Hamer and Leeman, 1981) . Neurotensin-like material has recently been isolated from pancreatic tumours secreting vasoactive intestinal polypeptide and other regulatory peptides (Gutniak et al., 1980; Feurle et al., 1980; Blackburn et al., 1981 
Results
Extracts from the patient's tumour contained 8 5 pmol/g wet weight of neurotensin-like immunoreactivity measured by radioimmunoassay using a specific rabbit antiserum and 125 labelled synthetic neurotensin (Blackburn and Bloom, 1979) . Gel permeation chromatography showed the presence of two molecular forms of neurotensin-like immunoreactivity one of which coeluted with the synthetic tridecapeptide (Fig. 1) Somatostatin, bombesin, gastrin, cholecystokinin, substance P, VIP, calcitonin, thyroid stimulating hormone, adrenocorticotrophic hormone, follicle stimulating hormone and luteinising hormone were all undetectable in plasma.
Discussion
This is the first description of neurotensin-like material in a lung tumour. Neurotensin-like immunoreactivity has recently been found in pancreatic tumours in association with abnormal production of other peptides. Six out of twenty-one tumours producing VIP also contained neurotensin-like immunoreactivity (Blackburn et al., 1981) , two of which were associated with high plasma neurotensin concentrations. Neurotensin-like immunoreactivity has also been found in two other mixed endocrine tumours, one patient presenting with the Zollinger-Ellison syndrome (Feurle et al., 1980) , the other with watery diarrhoea (Gutniak et al., 1980) . In contrast to pancreatic tumours only neurotensin (within the limitation of the peptides measured) was detected in the present tumour. This case therefore provided an opportunity to assess the clinical effects of neurotensin hypersecretion. The contribution of an elevated plasma neurotensin to the clinical course of the present patient, however, remains speculative. Fasting hyperglycaemia in a cachectic, anorexic man is unusual and may be relevant as neurotensin induces hyperglycaemia in animals. The patient reported by Gutniak and colleagues was also diabetic but this may have related to the elevated VIP concentration. Neurotensin has vascular effects in animals and might therefore have contributed to the clubbing and hypertrophic pulmonary osteoarthropathy.
